Plasma derived medicines are gaining popularity increasingly. The plasma must be non-damaging to the surrounding tissue, and its discharge current must be kept below the permissible levels to treat living tissue. Special atmospheric discharges can help alleviate these problems. This article discusses several applications of plasma medicine. The main advantage of plasma medicine over traditional methods is that it can be used in more areas than conventional treatments. It also has an extensive list of benefits, including improved patient care, accelerated healing, and even the treatment of wounds.
While the exact mechanisms by which plasma derived medicines affect cells and tissues are not fully understood, they are rapidly becoming more well-known. In addition to its anti-inflammatory and wound-healing properties, plasma is also believed to stimulate the body’s own repair mechanisms. The plasma contains oxygen and nitrogen-based reactive species. In addition to their antimicrobial properties, plasma induces the regeneration of mammalian cells and stimulates tissue repair.
As per report published by Coherent Market Insights, Plasma Derived Medicine Market is estimated to be valued at US$ 33,450 million in 2021 and expected to exhibit a CAGR of 6.8% during the forecast period (2021-2028).
Although plasma derived medicines are a relatively new field, their promise is clear. Currently, cold atmospheric pressure plasma devices have received CE certification for the treatment of chronic wounds and pathogen-based skin diseases. Currently, plasma derived medicine is an evolving field of research focusing on the direct application of physical plasma to the human body. The goal of applied plasma medicine is to exploit the different interactions of various plasma components with living cells to normalize therapeutic effects. In a laboratory setting, plasma is used to treat cancer and wounds, and exposure to physical plasma can induce various effects, including cell stimulation and inhibition. But the primary medical application of plasma is in cancer treatment.
In regions such as Singapore, the increasing prevalence of pharmaceutical companies has increased the demand for plasma derived medicines. For instance, according to Real Staffing, there are over 50 major pharmaceutical manufacturing facilities in Singapore. Almost 100 diseases require plasma derived medicines. In some cases, patients cannot produce the correct or sufficient proteins to fight disease. In these cases, replacement therapy is used to supplement missing or defective protein production. These disorders are congenital and patients are likely to need blood medicines for the rest of their lives. There is a wide range of treatments based on these plasma derived medicines.
